| Target Price | $163.20 |
| Price | $146.23 |
| Potential | 11.61% |
| Number of Estimates | 30 |
| 30 Analysts have issued a price target Procter & Gamble 2027 . The average Procter & Gamble target price is $163.20. This is 11.61% higher than the current stock price. The highest price target is $195.30 33.56% , the lowest is $144.43 1.23% . | |
| A rating was issued by 37 analysts: 19 Analysts recommend Procter & Gamble to buy, 17 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2027 of 11.61% . Most analysts recommend the Procter & Gamble stock at Purchase. |
30 Analysts have issued a sales forecast Procter & Gamble 2027 . The average Procter & Gamble sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an Procter & Gamble EBITDA forecast 2027. The average Procter & Gamble EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
32 Procter & Gamble Analysts have issued a net profit forecast 2027. The average Procter & Gamble net profit estimate is
This results in the following potential growth metrics and future Net Margins:
32 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is
This results in the following potential growth metrics and future valuations:
Procter & Gamble...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Hold
|
Downgrade | Aug 07 2026 |
| HSBC |
Buy
➜
Hold
|
Downgrade | Jul 30 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 21 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 16 2026 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Jul 10 2026 |
| Bernstein |
➜
Market Perform
|
Initiated | Jun 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Argus Research:
Buy
➜
Hold
|
Aug 07 2026 |
|
Downgrade
HSBC:
Buy
➜
Hold
|
Jul 30 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 21 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 16 2026 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jul 10 2026 |
|
Initiated
Bernstein:
➜
Market Perform
|
Jun 11 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


